Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

bdr pharma news

Tag: bdr pharma news

Read all Latest developments, information and news on and about Bdr pharma

BDR pharma have carved a niche for ourselves, with our formulations portfolio for specialty medication. Their expertise with life saving medicines help us in their early identification - Latest News

BDR Pharma launches generic APALUTAMIDE to treat Prostate cancer in India

Ruchika Sharma3 Jan 2023 12:00 PM IST

Apalutamide plus ADT (androgen-deprivation therapy) arm shows a significant decrease in the risk of disease progression and reduces risk of mortality...

CCI approves acquisition of minority stake of BDR Pharma by Multiples Private Equity Fund III, others

Ruchika Sharma19 April 2022 2:43 PM IST

The proposed combination relates to the acquisition of a minority stake by Multiples Fund III and Financial Investors in the Target.

BDR Pharma launches Enzalutamide under the brand name BDENZA

MD Bureau2 March 2022 1:16 PM IST

The objective behind the launch of Enzalutamide 160 mg is to ensure better efficacy and minimum side effects.

BDR Pharma launches India's first generic cancer treatment drug Midostaurin

Ruchika Sharma8 Dec 2021 4:20 PM IST

BDR Pharma has launched the country's first generic Midostaurin under the brand name MSTARIN to treat cancer.

BDR Pharma gets DCGI nod for generic antibiotic drug Biapenem

Ruchika Sharma25 Sept 2021 1:53 PM IST

Biapenem is a carbapenem used for treatment of moderate and severe bacterial infections.

BDR Pharma unveils generic cancer drug Cabozantinib in India

Ruchika Sharma15 Sept 2021 12:41 PM IST

New Delhi: Drug firm BDR Pharmaceuticals on Tuesday said it has launched generic Cabozantinib, used for the treatment of various types of cancer, and...

BDR Pharma, DRDO collaborate for COVID drug 2-DG production

Ruchika Sharma26 July 2021 1:00 PM IST

Last month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy in mild to severe...

Mankind Pharma, BDR Pharma partner for COVID drug Baricitinib in India

Ruchika Sharma25 Jun 2021 2:00 PM IST

New Delhi: Mankind Pharma has recently announced that the company has partnered with BDR Pharmaceuticals International Pvt. Ltd for distributing the...

BDR Pharma launches generic cancer drug Rucaparib in India

Ruchika Sharma28 May 2021 12:00 PM IST

The product is priced at MRP Rs 54,000(Bottle of 60) for 300 Mg dose & MRP Rs 45,000 (Bottle of 60) for 200 Mg dose.

Eli Lilly, BDR Pharma ink pact for COVID drug Baricitinib

Ruchika Sharma23 May 2021 9:00 AM IST

New Delhi: Drug firm BDR Pharma on Wednesday said it has inked a licensing pact with Eli Lilly and Company for the manufacturing and distribution...

BDR Pharma launches generic version of Lenvatinib for cancer treatment in India

Ruchika Sharma22 Oct 2020 10:00 AM IST

Lenvatinib is a molecule used to provide breakthrough therapy treatment for cancer patients.

BDR Pharma unveils idiopathic pulmonary fibrosis drug Nintedanib in India

Ruchika Sharma20 Oct 2020 11:06 AM IST

IPF is lung disorder where there is scarring of the lungs due to an unknown cause, BDR Pharmaceuticals said in a statement.

Journal Club Today

Health News Today

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok